In this discussion, an EU-based KOL speaks about the safety of currently available treatment options and future market potential. We also discuss trending topics such as combination trials, novel oral treatments, and patient segmentation across different treatment options and clinical trial designs. 

This interview was conducted on 4 July 2024. 

If you are a KOL Insight subscriber, you may also access the interview from our KOL Insight portal. 

Biomedtracker’s KOL Insight transcripts are available through subscription only. For more information on obtaining a KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (888) 670-8900. 

For our disclosures, please read the Biomedtracker Research Standards.